Definitive Contract W911QY25C0015
- Not listed
- This is a $240,000.00 firm fixed price contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Intralytix Inc., a for-profit biotech organization that specializes in bacteriophage-based products for food safety and public health applications. The contract, which does not have a set-aside designation, is for the "Elucidation of Interaction of Bacteriophages with Bacteria in Various Food Matrixes, and the Impact on the Food...
- The Department of the Army Medical Command awarded a $1,099,973.44 firm fixed price contract to Physical Sciences Inc., doing business as Physical Sciences Inc., for research and development of Stabilized, Freeze-Dried Bacteriophage for Use in Austere Environments under a Small Business Technology Transfer Phase II solicitation. The prime contractor Physical Sciences Inc. will perform the entirety of the contract from its location in Andover, Massachusetts over a period of two years from March...
- The Department of the Army Materiel Command Research Development and Engineering Command awarded a firm fixed price contract valued at ninety-nine thousand nine hundred sixty-eight dollars to The Charles Stark Draper Laboratory, Inc. (Draper) to identify bacteriophages under Task 1 of an unspecified effort. No set-aside designation applied. Performance will occur in Natick, Massachusetts with an anticipated completion date of October 31, 2021. As a not-for-profit research organization, Draper...
- The Department of the Army Medical Command awarded a $166,492.05 Small Business Innovation Research (SBIR) Phase I contract to CFD Research Corporation, doing business as CFD Research, for the development of a "Portable Automated Phage Isolation Technology." This firm-fixed-price contract was set aside for small businesses. CFD Research, a for-profit engineering and technology services firm, has a history of providing computational fluid dynamics research, artificial intelligence,...
- This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Specific Diagnostics, Inc., a for-profit small business, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development titled "Rapid Bacteriophage Susceptibility Testing Using Small Molecule Sensor Technology" and has a potential value of $248,845.27. The contract was awarded on March 2, 2021, with an expected completion date of...
- This federal contract award was issued by the Defense Health Agency (DHA) to Charlot Biosciences Inc., a minority-owned, small disadvantaged business, for a Phase I Small Business Innovation Research (SBIR) project titled "Rapid Detection of Bacteriophage Susceptibility in Antibiotic-Resistant Pathogens Using Cellphoresis". The firm-fixed-price purchase order has a potential value of $249,534.00 and a completion date of September 7, 2021. The contract is set aside for small...
- The Defense Health Agency awarded a $1.1M Small Business Technology Transfer Phase II contract to CFD Research Corporation for the development of portable phage preparation technology for field application under proposal number A2-9480. The contract, awarded July 3, 2023, with a completion date of May 2, 2026, is structured as a firm fixed-price definitive contract. As a designated small business set-aside award, this STTR Phase II effort builds upon earlier research to advance bacteriophage...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command (MEDCOM) to Memsel Inc., a self-certified small disadvantaged business. The $249,918.26 contract is for the development of a multi-component hydrogel containing stabilized, encapsulated bacteriophages for the treatment of drug-resistant bacterial infections. This SBIR Phase I contract was set aside for small businesses and is part of MEDCOM's broader efforts to identify...
- This firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Synbio Technologies LLC, a small business located in Monmouth Junction, New Jersey. The $11,994.20 contract is for the delivery of a synthetic plasmid containing the AP50c phage genome, modified to include an eGFP tag. The requirement was originally posted as a special notice by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Fabrico Technology, Inc., a minority-owned small business. The contract is for the development of a "Field Portable Coliform Bacteria & E. Coli RNA Biomarker LAMP - OSD System," which is a research and development effort related to chemical and biological defense. The contract has a firm-fixed-price of $999,999.53 and is set to be completed by January 26, 2021....
The U.S. Army Combat Capabilities Development Command (CCDC) awarded a $249,970 firm-fixed-price definitive contract to Intralytix Inc. on February 13, 2025, to develop and optimize a stable dry formulation of PhageSafe, a bacteriophage-based antimicrobial preparation targeting three major foodborne bacterial pathogens of concern to the Army: Listeria monocytogenes, Salmonella, and Escherichia coli STEC. The contract, which originated from a Broad Agency Announcement seeking basic and applied research in support of Soldier protection and survivability, carries an ultimate completion date of February 19, 2029, and will be performed at the contractor's facility in Columbia, Maryland. No set-aside designation was applied to this award. Intralytix Inc., a biotechnology company specializing in bacteriophage-based solutions for food safety and pathogen control, is well-positioned to execute this research and development effort. The company brings substantial relevant experience, including prior federal contracts and grants focused on phage technology applications in food processing environments, such as its USDA-funded SalmoFresh project for Salmonella reduction in poultry processing. This contract represents the Army's investment in innovative biological solutions to enhance food safety within military food supply chains and supports the broader defense mission of protecting Soldier health and operational readiness.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Broad Agency Announcement for Basic and Applied Research at the US Army Combat Capabilities Development Command - Soldier Center | W911QY25R0023 | Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground | Solicitation 3/3 | 3/3/25, 9:27 AM | |
Broad Agency Announcement for Basic and Applied Research at the US Army Combat Capabilities Development Command - Soldier Center | W911QY20R0022 | Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground | Solicitation 2/3 | 2/28/20, 2:21 PM | |
Broad Agency Announcement for Basic and Applied Research at the US Army Combat Capabilities Development Command - Soldier Center | W911QY20R0022 | Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground | Pre-Solicitation 1/3 | 2/6/20, 4:03 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Funding Only Action | $99.0k | 12/15/25 | |
| P00003 | Other Administrative Action | $0 | 5/8/25 | |
| P00002 | Other Administrative Action | $0 | 4/29/25 | |
| P00001 | Other Administrative Action | $0 | 4/22/25 | |
| Not listed | Not listed | $79.8k | 2/13/25 |